— Know what they know.
Not Investment Advice

NRC NASDAQ

National Research Corporation
1W: +0.6% 1M: +8.8% 3M: +39.3% YTD: +23.9% 1Y: +79.5% 3Y: -54.4% 5Y: -54.8%
$19.08
+0.04 (+0.21%)
 
Weekly Expected Move ±6.7%
$16 $17 $19 $20 $21
NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Strong Buy · Power 66 · $430.0M mcap · 13M float · 0.774% daily turnover · Short 33% of daily vol

Revenue Segmentation

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$137M -4.0% ▼
5Y CAGR: +0.6%
Gross Profit
$77M -10.1% ▼
5Y CAGR: -1.6%
Operating Income
$23M -35.8% ▼
5Y CAGR: -11.9%
Net Income
$12M -53.2% ▼
5Y CAGR: -20.8%
EPS (Diluted)
$0.52 -50.0% ▼
5Y CAGR: -18.5%
EBITDA
$30M -26.8% ▼
5Y CAGR: -9.9%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$148M$152M$149M$143M$137M
YoY Growth+11.0%+2.4%-2.0%-3.7%-4.0%
Cost of Revenue$52M$57M$56M$57M$60M
Gross Profit$96M$95M$93M$86M$77M
Gross Margin64.6%62.4%62.3%60.2%56.3%
R&D Expenses$0$0$0$0$0
SG&A Expenses$39M$43M$47M$45M$55M
Operating Expenses$45M$48M$53M$51M$55M
Operating Income$50M$47M$40M$35M$23M
Operating Margin34.0%30.7%27.0%24.6%16.4%
Interest Expense$2M$1M$862K$3M$5M
Income Before Tax$49M$43M$40M$33M$18M
Tax Expense$11M$11M$9M$8M$6M
Net Income$37M$32M$31M$25M$12M
Net Margin25.3%21.0%20.8%17.3%8.4%
EPS (Diluted)$1.46$1.27$1.25$1.04$0.52
EBITDA$57M$49M$46M$41M$30M
Shares Outstanding26M25M25M24M22M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms